Is insurance going to cover Inspire? Most major insurance companies reimburse Inspire, either as part of a covered coverage or on an individual basis. Your doctor and the Inspire insurance team will work with you to get you approved.
How much does inspire device cost?
Inspire Surgery Costs The Inspire gadget currently costs between $30,000 and $40,000 to install, including surgery fees, and the battery change can cost another $17,000. Insurance may cover these expenses.
How long does inspire surgery take?
– Inspire is usually implanted as an outpatient surgery that takes about 3 hours. Your doctor may recommend a one night stay in the hospital in certain conditions. – The amount of pain experienced following the treatment varies, but it is usually not significant.
Who Cannot use inspire?
What exactly is it? The Inspire Upper Airway Stimulation (UAS) system is a neural stimulator that is implanted to treat obstructive sleep apnea in people who have moderate to severe obstructive sleep apnea (OSA). The implantable pulse generator (IPG), stimulation lead, and sensor lead are all part of the Inspire UAS system, as are external components like the physician programmer and patient programmer.
This approval broadens the indications for the Inspire UAS’s usage in patients aged 18 to 21 who have moderate to severe OSA and who:
- Tonsils and other soft tissue behind the nose cannot be removed, or cannot be treated adequately.
- Despite attempts to enhance compliance, have been confirmed to fail or cannot tolerate PAP therapy.
- Have considered all possible alternative/adjunct therapy in accordance with standard of care
What is the mechanism behind it? The implantable pulse generator senses the patient’s breathing pattern and uses modest nerve stimulation to keep the airway open. The external physician programmer allows the physician to customize the stimulation settings. The patient sleep remote enables them to turn on therapy before going to bed and turn it off when they wake up.
When does it come into play? A fraction of patients with moderate to severe OSA are treated with the Inspire UAS system. A scale called the apnea-hypopnea index is used to measure the severity of apnea (lack of breath) or hypopnea (partial loss of breath) (AHI). An AHI of greater than or equal to 15 and less than or equal to 65 is considered moderate to severe OSA. Adult patients aged 18 and up who have been confirmed to fail or cannot tolerate positive airway pressure (PAP) treatments (such as continuous positive airway pressure or bi-level positive airway pressure machines) and do not have a complete blockage of the upper airway are candidates for Inspire UAS.
PAP failure is described as the inability to completely remove OSA (even using a PAP), while PAP intolerance is characterized as:
- Unable to use PAP (for more than 5 nights per week; usage defined as more than 4 hours per night) or inability to utilize PAP (for more than 5 nights per week)
- Reluctance to utilize PAP (for example, a patient returns the PAP system after attempting to use it).
What will it achieve? A clinical trial involving 126 patients was conducted across 22 investigational sites to support the FDA’s initial approval of Inspire UAS. The majority of patients who received Inspire UAS therapy saw clinically significant reductions in the severity of their obstructive sleep apnea and increases in their quality of life. At the 12-month endpoint, more than half of the patients were considered responders to Inspire UAS therapy, with an AHI decrease of at least 50% and an AHI of less than 20 occurrences per hour. The oxygen desaturation index (ODI), a rating used to indicate the severity of sleep apnea, was also reduced by at least 25% in Inspire UAS therapy responders. The findings of this investigation, along with those of a small clinical trial in juvenile Down Syndrome patients, supported the expansion of the indications to cover older teenagers aged 18 to 21.
When is it not appropriate to use it? The following activities should not be carried out with the Inspire UAS system:
- Other than obstructive apnea, other types of apnea (central and mixed) account for more than 25% of the total AHI.
- Any physical finding that would jeopardize the effectiveness of upper airway stimulation, such as full upper airway obstruction.
- Any condition or surgery that has weakened upper airway neurological control
- Patients who are unable to utilize the sleep remote or do not have the essential help
- Patients who have an implantable device that could interact with the Inspire system in an unforeseen way. Consult the device’s manufacturer to see whether there’s a chance of a conflict.
- Patients who need magnetic resonance imaging (MRI) for reasons other than those listed in the MR Conditional labeling
Can Inspire be removed?
002 Inspire Inspire therapy may or may not be effective for everyone. To treat your sleep apnea, your doctor may need to take further measures. There are other dangers in uninstalling your system. Another operation will be required if you and your doctor decide to remove the system.
Does inspire stop snoring?
The Inspire device’s advantages and disadvantages The Inspire device appears to prevent sleep apnea or considerably reduce snoring and daytime tiredness, according to research.
Does Medicare pay inspire implants?
Inspire is covered by Medicare for those who qualify. During an office visit, a doctor versed in the Inspire technique can review the qualifications with you.